Chen, A. (2025) “CD19 And CD22 Dual-Target CAR-T Therapy Via CRISPR/Cas9 Engineering for Relapsed B-Cell Acute Lymphoblastic Leukemia”, Academic Journal of Science and Technology, 18(1), pp. 621–625. doi:10.54097/79zwp242.